Core Scientific Confirms CORZQ Stock, Warrants Trading Post-Bankruptcy

TL;DR

**Core Scientific's stock (CORZQ) and warrants are officially trading, confirming its post-bankruptcy market presence.**

AI Summary

Core Scientific, Inc. filed an 8-K on January 8, 2024, reporting an event that occurred on January 5, 2024. The filing indicates that the company's common stock, with a par value of $0.0001 per share, is traded under the symbol CORZQ, and its warrants are also listed. This matters to investors because it confirms the current trading status of Core Scientific's securities, which is particularly relevant given its recent emergence from bankruptcy, signaling its continued presence on public exchanges.

Why It Matters

This filing confirms the continued public trading of Core Scientific's common stock and warrants, which is crucial for investors to understand the liquidity and market access for their holdings.

Risk Assessment

Risk Level: medium — While confirming trading is positive, the 'CORZQ' ticker indicates the company is still in a distressed or post-bankruptcy state, carrying inherent risks.

Analyst Insight

Investors should note the CORZQ ticker, which often signifies a company in or recently emerged from bankruptcy, and conduct thorough due diligence on the company's financial health and restructuring plan before making investment decisions.

Key Numbers

• $0.0001 — Par value per share (The stated par value for Core Scientific's common stock.)

Key Players & Entities

• Core Scientific, Inc. (company) — the registrant filing the 8-K
• $0.0001 (dollar_amount) — par value per share of common stock
• January 5, 2024 (date) — date of earliest event reported
• January 8, 2024 (date) — date the 8-K was filed

Forward-Looking Statements

• Core Scientific will continue to trade on public exchanges under the CORZQ ticker for the foreseeable future. (Core Scientific, Inc.) — high confidence, target: 2025-01-01

FAQ

Key Financial Figures

• $0.0001 — ich registered Common stock, par value $0.0001 per share CORZQ * Warrants, exerc
• $55 million — ERO Shares ") in an aggregate amount of $55 million. Also, as previously disclosed, on Nove
• $37.1 million — d to severally and not jointly backstop $37.1 million of the Equity Rights Offering (the " Ba

Filing Documents

• d109221d8k.htm (8-K) — 42KB
• d109221dex991.htm (EX-99.1) — 3985KB
• d109221dex992.htm (EX-99.2) — 14KB
• g109221529.jpg (GRAPHIC) — 2KB
• g109221533.jpg (GRAPHIC) — 2KB
• g109221534.jpg (GRAPHIC) — 3KB
• g109221535a.jpg (GRAPHIC) — 3KB
• g109221535b.jpg (GRAPHIC) — 3KB
• g109221536.jpg (GRAPHIC) — 4KB
• g109221545.jpg (GRAPHIC) — 2KB
• g109221547.jpg (GRAPHIC) — 4KB
• g109221g00p42.jpg (GRAPHIC) — 6KB
• g109221g0108114819457.jpg (GRAPHIC) — 2KB
• g109221g0108114819580.jpg (GRAPHIC) — 2KB
• 0001193125-24-004018.txt ( ) — 5124KB
• corzq-20240105.xsd (EX-101.SCH) — 3KB
• corzq-20240105_def.xml (EX-101.DEF) — 14KB
• corzq-20240105_lab.xml (EX-101.LAB) — 23KB
• corzq-20240105_pre.xml (EX-101.PRE) — 14KB
• d109221d8k_htm.xml (XML) — 6KB

01

Item 7.01 Regulation FD Disclosure. As previously disclosed, on December 21, 2022, Core Scientific, Inc. (the " Company ") and certain of its affiliates (collectively, the " Debtors ") filed voluntary petitions (the " Chapter 11 Cases ") in the United States Bankruptcy Court for the Southern District of Texas (the " Bankruptcy Court ") seeking relief under Chapter 11 of Title 11 of the United States Code (the " Bankruptcy Code "). The Debtors continue to operate their business and manage their properties as "debtors-in-possession" under the jurisdiction of the Bankruptcy Court and in accordance with the applicable provisions of the Bankruptcy Code and orders of the Bankruptcy Court. Additional information about the Chapter 11 Cases, including access to Court documents, is available online at cases.stretto.com/CoreScientific/, a website administered by Stretto, Inc., a third-party bankruptcy claims and noticing agent. The information on this web site is not incorporated by reference into, and does not constitute part of, this Form 8-K. Plan Supplement As previously disclosed, the Debtors filed with the Bankruptcy Court (i) on November 16, 2023, the Third Amended Joint Chapter 11 Plan of Reorganization of Core Scientific, Inc. and its Debtor Affiliates (the " Third Amended Plan ") and the related Disclosure Statement (the " Initial Disclosure Statement "); (ii) on December 8, 2023, a supplement to the Third Amended Plan (the " Initial Plan Supplement "); (iii) on December 11, 2023, a further supplement to the Third Amended Plan (the " Amended Plan Supplement ); (iv) on December 26, 2023, the Fourth Amended Joint Chapter 11 Plan of Reorganization of Core Scientific, Inc. and its Debtor Affiliates (the " Fourth Amended Plan "); (v) on December 27, 2023, a supplement to the Fourth Amended Plan (the " Second Amended Plan Supplement "); and (vi) on December 28, 2023, the solicitation versions of the Fourth Amended Plan (the " Plan ") and the supplement to the Disclos

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits: Exhibit Description 99.1 Third Amended Plan Supplement, dated as of January 5, 2024 99.2 Press Release, dated January 8, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Core Scientific, Inc. Date: January 8, 2024 By: /s/ Todd M. DuChene Name: Todd M. DuChene Title: Chief Legal Officer and Chief Administrative Officer

View Full Filing

View this 8-K filing on SEC EDGAR